相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight
Isaac J. Perales et al.
ANNALS OF PHARMACOTHERAPY (2020)
Patients with higher body mass index treated with direct/novel oral anticoagulants (DOAC/NOAC) for atrial fibrillation experience worse clinical outcomes
Marko Lucijanic et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study
Steve Deitelzweig et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis
Victoria Speed et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A single center retrospective cohort study evaluating use of direct oral anticoagulants (DOACs) in morbidly obese veteran population
Tanvi Patil et al.
THROMBOSIS RESEARCH (2020)
Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation
Kazuhiko Kido et al.
ANNALS OF PHARMACOTHERAPY (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
Margarita Kushnir et al.
LANCET HAEMATOLOGY (2019)
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight Insights From the ARISTOTLE Trial
Stefan H. Hohnloser et al.
CIRCULATION (2019)
Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study
Siavash Piran et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
K. Martin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
National Trends in Ambulatory Oral Anticoagulant Use
Geoffrey D. Barnes et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
分享论文
